Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Copa Holdings
CPA
$6.2B
| $10M | 0.01% |
+89,200
| New | +$9.08M |
|
1252
Benchmark Electronics
BHE
$2.95B
| $9.99M | 0.01% |
314,250
-7,950
| -2% | -$249K |
|
1253
Target
TGT
$70.2B
| $9.99M | 0.01% |
181,000
-1,608,800
| -90% | -$100M |
|
|
SWC
1254
DELISTED
Stillwater Mining Co
SWC
| $9.97M | 0.01% |
577,200
-376,900
| -40% | -$6.44M |
|
|
BPY
1255
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $9.92M | 0.01% |
445,398
+153,156
| +52% | +$3.42M |
|
1256
Tetra Tech
TTEK
$9.09B
| $9.91M | 0.01% |
1,213,600
+663,100
| +120% | +$5.5M |
|
1257
Willis Lease Finance
WLFC
$1.15B
| $9.91M | 0.01% |
1,330,800
+106,200
| +9% | +$895K |
|
|
TVPT
1258
DELISTED
Travelport Worldwide Limited
TVPT
| $9.89M | 0.01% |
840,236
-39,864
| -5% | -$530K |
|
1259
Marcus Corp
MCS
$924M
| $9.84M | 0.01% |
306,400
+68,700
| +29% | +$2.12M |
|
|
TA
1260
DELISTED
TravelCenters of America LLC
TA
| $9.83M | 0.01% |
322,320
-40
| -0% | -$1.35K |
|
|
FCH
1261
DELISTED
Felcor Lodging Trust
FCH
| $9.82M | 0.01% |
1,307,000
-441,402
| -25% | -$3.35M |
|
1262
Stratasys
SSYS
$774M
| $9.79M | 0.01% |
477,600
-253,300
| -35% | -$5.01M |
|
|
ODP
1263
DELISTED
ODP
ODP
| $9.77M | 0.01% |
209,383
-234,760
| -53% | -$10.6M |
|
|
CLVS
1264
DELISTED
Clovis Oncology, Inc.
CLVS
| $9.77M | 0.01% |
153,400
+71,300
| +87% | +$4.33M |
|
1265
Mesa Laboratories
MLAB
$641M
| $9.76M | 0.01% |
79,500
-3,800
| -5% | -$465K |
|
|
PCTI
1266
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $9.73M | 0.01% |
1,367,099
+115,800
| +9% | +$659K |
|
|
CUB
1267
DELISTED
Cubic Corporation
CUB
| $9.73M | 0.01% |
184,200
+2,300
| +1% | +$116K |
|
|
CTRL
1268
DELISTED
Control4 Corporation
CTRL
| $9.71M | 0.01% |
614,700
+354,000
| +136% | +$4.74M |
|
1269
AngloGold Ashanti
AU
$48.1B
| $9.65M | 0.01% |
896,400
-2,822,200
| -76% | -$33M |
|
|
ARRS
1270
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $9.65M | 0.01% |
364,800
-129,800
| -26% | -$3.63M |
|
|
PSTB
1271
DELISTED
Park Sterling Corp.
PSTB
| $9.63M | 0.01% |
782,123
-21,100
| -3% | -$245K |
|
|
XCRA
1272
DELISTED
Xcerra Corporation
XCRA
| $9.63M | 0.01% |
1,082,899
-35,100
| -3% | -$290K |
|
|
SVA
1273
DELISTED
Sinovac Biotech, Ltd
SVA
| $9.62M | 0.01% |
1,679,490
+154,690
| +10% | +$896K |
|
1274
CME Group
CME
$94.9B
| $9.62M | 0.01% |
80,995
-344,597
| -81% | -$41.4M |
|
|
BFYT
1275
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $9.6M | 0.01% |
600,203
+386,303
| +181% | +$6.88M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.